Your browser doesn't support javascript.
loading
Immune deficiency and autoimmunity in patients with CTLA-4 (CD152) mutations.
Verma, N; Burns, S O; Walker, L S K; Sansom, D M.
Afiliação
  • Verma N; Clinical Immunology Department, Royal Free Hospital, London, UK.
  • Burns SO; Clinical Immunology Department, Royal Free Hospital, London, UK.
  • Walker LSK; Division of Infection and Immunity, School of Life and Medical Sciences, Institute of Immunity and Transplantation, University College London, Royal Free Hospital, London, UK.
  • Sansom DM; Division of Infection and Immunity, School of Life and Medical Sciences, Institute of Immunity and Transplantation, University College London, Royal Free Hospital, London, UK.
Clin Exp Immunol ; 190(1): 1-7, 2017 10.
Article em En | MEDLINE | ID: mdl-28600865
ABSTRACT
Immune deficiency disorders are a heterogeneous group of diseases of variable genetic aetiology. While the hallmark of immunodeficiency is susceptibility to infection, it is increasingly clear that autoimmunity is prevalent, suggestive of a more general immune dysregulation in some cases. With the increasing use of genetic technologies, the underlying causes of immune dysregulation are beginning to emerge. Here we provide a review of the heterozygous mutations found in the immune checkpoint protein CTLA-4, identified in cases of common variable immunodeficiency disorders (CVID) with accompanying autoimmunity. Study of these mutations provides insights into the biology of CTLA-4 as well as suggesting approaches for rational treatment of these patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Imunodeficiência de Variável Comum / Antígeno CTLA-4 / Imunoterapia / Mutação Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Clin Exp Immunol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Imunodeficiência de Variável Comum / Antígeno CTLA-4 / Imunoterapia / Mutação Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Clin Exp Immunol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido